Andrea Cercek
Dr. Andrea Cercek is a leading oncologist at Memorial Sloan Kettering Cancer Center, specializing in the treatment of gastrointestinal cancers. She has been instrumental in advancing research on immunotherapy, particularly in the application of novel drugs like dostarlimab for treating patients with solid tumors. Cercek's work focuses on improving patient outcomes by exploring less invasive treatment options and enhancing the effectiveness of the immune system in fighting cancer.
Not in the pool (under ¢1).
Recent news mentions
Andrea Cercek is an oncologist at Memorial Sloan Kettering Cancer Center who commented on the study regarding the increasing incidence of appendiceal cancer.
Cânceres raros de apêndice estão aumentando entre millennials e a geração X; entenda
Brazil· 2025-06-11
Andrea Cercek is one of the oncologists leading the research on the new cancer treatment.
Un anticuerpo humanizado de ratón hace desaparecer el cáncer de 84 personas con una mutación genética | Salud y bienestar
Spain· 2025-05-09
Dr. Andrea Cercek, a gastrointestinal oncologist, oversaw the research along with fellow gastrointestinal oncologist Dr. Luiz Diaz.
Medication alternative for cancer patients uses immunotherapy to avoid surgery, chemo
United States· 2025-04-29
Dr. Andrea Cercek was part of the research team that decided to give dostarlimab on its own.
Immunotherapy Drug Spares Cancer Patients From Grisly Surgeries and Harsh TherapiesUnited States· 2025-04-27